Organization · Family Office
Colt Ventures
Colt Ventures is a diversified investment firm based in Dallas, TX, focusing on sectors such as biotechnology, technology, and real estate. It operates as a family office, investing personal capital in both private and public markets.
Overview
What Colt Ventures does
What Colt Ventures is
Colt Ventures is a diversified investment firm based in Dallas, TX, focusing on sectors such as biotechnology, technology, and real estate. It operates as a family office, investing personal capital in both private and public markets.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Founded
- Founded in 2003
- Approximate age
- About 23 years
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find Colt Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Colt Ventures as a funder
Investment thesis
Colt Ventures invests in opportunities that demonstrate a meaningful impact on people's lives, focusing on inefficient markets and proven management teams. The firm seeks investments before significant value-creating inflection points and emphasizes near-term liquidity.
Focus narrative
Colt Ventures invests in a range of sectors, including biotechnology, oil & gas, technology, real estate, consumer & retail, and financial services. The firm typically invests up to $15 million per deal, concentrating on inefficient markets and proven management teams, with an emphasis on significant near-term value inflection points and liquidity horizons.
Value beyond capital
Colt Ventures adds value by leveraging its extensive network of innovators, executives, and institutional investors to source and evaluate investment opportunities. The firm focuses on backing proven management teams and investing at critical points that can lead to significant value creation.
Terms and economics
- Typical check
- $1,000,000–$15,000,000
- Sweet spot
- $10,000,000
Focus and fit
- Stages
- Friends and Family · Angel · Seed · Series A · Series B · Series C · Series D · Growth Equity
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- ArQule, Kite Pharma, and OSI Pharmaceuticals
Portfolio context
Notable portfolio companies include Alterome Therapeutics, Erasca (NASDAQ: ERAS), Rocket Pharmaceuticals (NASDAQ: RCKT), ARS Pharmaceuticals (formerly Silverback Therapeutics, NASDAQ: SPRY), and Rumble (NASDAQ: RUM). Colt Ventures has also had successful exits with companies like ArQule, acquired by Merck for $2.7B, Kite Pharma, acquired by Gilead for $11.9B, and OSI Pharmaceuticals, acquired by Astellas for $4.0B.
Common questions
What to know about Colt Ventures
Upseed classifies Colt Ventures under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.